相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
Juan Carlos Hernandez-Boluda et al.
LEUKEMIA (2021)
Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management
Ayalew Tefferi
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
Nicolaus Kroeger et al.
LEUKEMIA (2021)
Missing data: the impact of what is not there
Rolf H. H. Groenwold et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Survival following allogeneic transplant in patients with myelofibrosis
Krisstina Gowin et al.
BLOOD ADVANCES (2020)
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis
Tania Jain et al.
BONE MARROW TRANSPLANTATION (2019)
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation
Nico Gagelmann et al.
BLOOD (2019)
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Marie Robin et al.
HAEMATOLOGICA (2019)
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Donal McLornan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis
Roni Tamari et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group
Francesca Patriarca et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Outcome after Transplantation According to Reduced-Intensity Conditioning Regimen in Patients Undergoing Transplantation for Myelofibrosis
Marie Robin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.
Mohamed Shanavas et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Myeloproliferative Neoplasms A Contemporary Review
Ayalew Tefferi et al.
JAMA ONCOLOGY (2015)
Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research
Vikas Gupta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis
Damiano Rondelli et al.
BLOOD (2014)
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
Claire Harrison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Outcome of Transplantation for Myelofibrosis
Karen K. Ballen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Defining the Intensity of Conditioning Regimens: Working Definitions
Andrea Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
Sergio Giralt et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Nicolaus Kroeger et al.
BLOOD (2009)
The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research
M. M. Horowitz
BONE MARROW TRANSPLANTATION (2008)
分享论文
